Tela Bio
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $16,091 | $16,603 | $16,998 | $15,052 |
Gross Profit | 11,073 | 11,336 | 11,624 | 10,389 |
EBITDA | -11,321 | -12,172 | -12,117 | -9,623 |
EBIT | -11,570 | -12,406 | -12,278 | -9,841 |
Net Income | -12,600 | -5,661 | -12,890 | -10,957 |
Net Change In Cash | 16,091 | 16,603 | 16,998 | 15,052 |
Free Cash Flow | -10,996 | -14,688 | -11,256 | -7,102 |
Cash | 26,496 | 37,143 | 46,729 | 58,202 |
Basic Shares | 24,663 | 24,579 | 24,490 | 24,483 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $58,453 | $41,418 | $29,463 | $18,213 |
Gross Profit | 40,112 | 27,044 | 18,813 | 11,234 |
EBITDA | -43,267 | -39,017 | -29,679 | -25,230 |
EBIT | -44,075 | -40,204 | -30,214 | -25,755 |
Net Income | -46,664 | -44,337 | -36,110 | -31,878 |
Net Change In Cash | 58,453 | 41,418 | 29,463 | 18,213 |
Cost of Revenue | -1,768 | -30,474 | ||
Free Cash Flow | -41,468 | -42,620 | -31,059 | -24,623 |
Cash | 46,729 | 42,019 | 43,931 | 74,394 |
Basic Shares | 22,868 | 16,267 | 14,473 | 12,934 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.51 |
2024-03-31 | -$0.23 |
2023-12-31 | -$0.53 |
2023-09-30 | -$0.45 |
